Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1188 results for "astrazeneca"

AstraZeneca plc (ADR) (AZN) Declares Semiannual Dividend of $0.90
American Banking News

AstraZeneca plc (ADR) (AZN) Declares Semiannual Dividend of $0.90

AstraZeneca plc (NYSE:AZN) declared a semiannual dividend on Friday, August 1st, AnalystRatings.NET reports. Shareholders of record on Friday, August 15th will be given a dividend of 0.90 per share on Monday, September 15th. This represents a yield ... American Banking News, 43 minutes ago

2,214 images for astrazeneca

American Banking News, 3 days ago
French Tribune, 4 days ago
Med India, 3 days ago
Cambridge Network, 4 days ago
Pharma Letter, 4 days ago
Invezz, 4 days ago
Reuters India, 4 days ago
WBSM-AM, 4 days ago
2Degrees, 4 days ago
Laboratory Equipment, 3 days ago

AstraZeneca shows resilience

Ben Hirschler London ASTRAZENECA raised its sales and earnings forecasts for the year yesterday, showing resilience after seeing off a $118 billion (R1 trillion) takeover approach from rival Pfizer two months ago. Second-quarter sales and ...
 IOL17 hours ago AstraZeneca Ups '14 Outlook  FOXBusiness.com1 day ago AstraZeneca steps up push into cancer immunotherapy  CNBC1 day ago AstraZeneca raises forecasts  Reuters1 day ago
MedCity News

AZ and Roche join forces for lung cancer test

AZ and Roche have agreed to collaborate on the development of a diagnostic test for lung cancer. AstraZeneca (AZ) and Roche have announced they are joining forces to develop a diagnostic test to help identify the most suitable treatments for ...
 Pharma Field9 hours ago ASTRAZENECA : sweetens the pill as profit forecasts help boss Soriot  4 Traders17 hours ago Critical Alerts For Aegerion Pharmaceuticals, ZELTIQ Aesthetics, Endocyte, Broadcom, and AstraZeneca Released By InvestorsObserver  Digital Journal1 day ago AstraZeneca (AZN) Tops Q2 EPS by 21c; Boosts Outlook  Industrial Info Financials1 day ago
Philadelphia Business Journal

AstraZeneca to Buy Respiratory Drug Company, Amirall

AstraZeneca will reportedly pay $875 million initially, and up to $1.22 billion, depending on product development success, new product launches and sales. "A significant number of employees" will reportedly be transferred to AstraZeneca, the news ...
 Contract Pharma3 hours ago AstraZeneca Builds Respiratory Drug Portfolio in $2.1B Deal  Pharmaceutical Manufacturing Magazine1 day ago AstraZeneca stocks respiratory and cancer pipelines  RSC1 day ago AstraZeneca buys Spanish drug company's respiratory franchise for up to $2.1B  Philadelphia Business Journal2 days ago

AstraZeneca's Shares Changing Hands at Lower Prices on 1.4x Above-Average Volume (AZN)

(Financial News Network On) The price of AstraZeneca shares has slipped to $72.73 (a 0.1% change) on heavy trading volume. Today's volume of 2.7 million shares tops the average 30-day volume of 1.8 million shares. Spikes in volume can validate a ...
 Individual.com3 hours ago Volume Spike Detected in Shares of AstraZeneca as They Move Lower on 1.5x Above-Average Volume (AZN)  Individual.com3 days ago

Large cap M&A can power next leg of the bull market

Pfizer's failed bid for AstraZeneca was a significant turning point for the UK market this year, according to AXA Distribution manager Richard Marwood. He said the bid by the US group, which was partly motivated by the UK's favourable corporate ...
 Citywire11 hours ago

AstraZeneca (AZN) Beats on Q2 Earnings, Guidance Raised

AstraZeneca ( AZN ) reported second-quarter 2014 core earnings of $1.30 per American Depositary Share ( ADS ) beating the Zacks Consensus Estimate of $1.13. Earnings were also up 13% (at constant exchange rates or CER) year over year buoyed by ...
 Yahoo! Finance10 hours ago

Update: AstraZeneca's Earnings Beat Reaffirms Bull Thesis

Summary AstraZeneca is attempting to make an earnings comeback after being hindered by a series of patent expirations, which has taken a toll on revenues. Pfizer isn't budging with respect to unveiling whether it still has plans to acquire ...
 Seeking Alpha11 hours ago

AstraZeneca: 'Execution risk' to Pfizer deal

Tax inversion, one of the main drivers behind the Pfizer bid, has come under the spotlight in the U.S., with legislation backed by President Barack Obama that could retroactively wipe out the benefits of inversion being debated. Shire , another ...
 CNBC23 hours ago Pfizer bid for GSK "has some merits", says Berenberg  London South East9 hours ago Pfizer keeps silent on plans for AstraZeneca  PredictWallStreet2 days ago Pfizer bid for GSK 'has some merits', says Berenberg  Yahoo! UK and Ireland4 hours ago

AstraZeneca Group's (AZN) CEO Pascal Soriot on Q2 2014 Results - Earnings Call Transcript

Pascal Soriot Good afternoon, everybody. I'm Pascal Soriot and I'm joined today by Briggs Morrison, our EVP of Global Medicines Development and our Chief Medical Officer. I also have with me Marc Dunoyer, our CFO; Mene Pangalos, our EVP of ...
 Seeking Alpha20 hours ago AstraZeneca CEO trumpets Q2 victory as troops fortify against Pfizer's return  FiercePharma1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
Get updated on latest news & your favorite topics right in your inbox!
More     Less